PL3843702T4 - Natychmiastowo uwalniana kombinacja memantyny i donepezilu o ustalonej dawce - Google Patents
Natychmiastowo uwalniana kombinacja memantyny i donepezilu o ustalonej dawceInfo
- Publication number
- PL3843702T4 PL3843702T4 PL20732664.6T PL20732664T PL3843702T4 PL 3843702 T4 PL3843702 T4 PL 3843702T4 PL 20732664 T PL20732664 T PL 20732664T PL 3843702 T4 PL3843702 T4 PL 3843702T4
- Authority
- PL
- Poland
- Prior art keywords
- memantine
- donepezil
- immediate release
- fixed dose
- release combination
- Prior art date
Links
- ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical compound O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 title 2
- 229960003530 donepezil Drugs 0.000 title 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 title 1
- BUGYDGFZZOZRHP-UHFFFAOYSA-N memantine Chemical compound C1C(C2)CC3(C)CC1(C)CC2(N)C3 BUGYDGFZZOZRHP-UHFFFAOYSA-N 0.000 title 1
- 229960004640 memantine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT2019115557 | 2019-05-31 | ||
| PCT/IB2020/055137 WO2020240505A1 (fr) | 2019-05-31 | 2020-05-29 | Combinaison à dose fixe et à libération immédiate de mémantine et de donépézil |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL3843702T3 PL3843702T3 (pl) | 2024-04-08 |
| PL3843702T4 true PL3843702T4 (pl) | 2024-04-08 |
Family
ID=88650785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20732664.6T PL3843702T4 (pl) | 2019-05-31 | 2020-05-29 | Natychmiastowo uwalniana kombinacja memantyny i donepezilu o ustalonej dawce |
Country Status (7)
| Country | Link |
|---|---|
| ES (1) | ES2960207T3 (fr) |
| HU (1) | HUE063622T2 (fr) |
| LT (1) | LT3843702T (fr) |
| MA (1) | MA53513B1 (fr) |
| PL (1) | PL3843702T4 (fr) |
| RS (1) | RS64694B1 (fr) |
| SM (1) | SMT202300336T1 (fr) |
-
2020
- 2020-05-29 ES ES20732664T patent/ES2960207T3/es active Active
- 2020-05-29 SM SM20230336T patent/SMT202300336T1/it unknown
- 2020-05-29 RS RS20230893A patent/RS64694B1/sr unknown
- 2020-05-29 MA MA53513A patent/MA53513B1/fr unknown
- 2020-05-29 PL PL20732664.6T patent/PL3843702T4/pl unknown
- 2020-05-29 LT LTEPPCT/IB2020/055137T patent/LT3843702T/lt unknown
- 2020-05-29 HU HUE20732664A patent/HUE063622T2/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA53513B1 (fr) | 2023-10-31 |
| HUE063622T2 (hu) | 2024-01-28 |
| SMT202300336T1 (it) | 2023-11-13 |
| PL3843702T3 (pl) | 2024-04-08 |
| RS64694B1 (sr) | 2023-11-30 |
| LT3843702T (lt) | 2023-11-10 |
| ES2960207T3 (es) | 2024-03-01 |
| MA53513A (fr) | 2021-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL283134A (en) | Alcohol-resistant drug formulations | |
| EP3686201A4 (fr) | Inhibiteur de la réplication du virus de la grippe et son utilisation | |
| PL4272834T3 (pl) | Zastosowanie terapeutyczne mitochondriów i połączonych środków mitochondrialnych | |
| PT3717471T (pt) | Novos compostos e composições farmacêuticas dos mesmos para o tratamento de doenças | |
| EP3565812C0 (fr) | Composés se liant à la tubuline et leur usage thérapeutique | |
| EP3313350A4 (fr) | Conception et utilisation d'exosquelette de support de jambe | |
| IL258997B (en) | Honey-cannabinoid therapeutic composition | |
| PL4335517T3 (pl) | Podawanie i dawkowanie diaminofenotiazyn | |
| MA41794A (fr) | Agents thérapeutiques modifiés et compositions associées | |
| EP3310376A4 (fr) | Agents thérapeutiques modifiés et compositions associées | |
| DK3620174T3 (da) | Enhedsdosis af dengue-vaccine og indgivelse deraf | |
| MX2022005372A (es) | Combinaciones y formulaciones de dosis fijas que comprenden etc-1002 y una o mas estatinas. | |
| IL269236A (en) | Engineered antimicrobial amphiphilic peptides and methods of use | |
| EP3373907A4 (fr) | Compositions pharmaceutiques à libération prolongée et méthodes d'utilisation | |
| EP4031520A4 (fr) | Compositions d'imagerie et thérapeutiques | |
| IL290231A (en) | Mhc class ii molecules and methods of use thereof | |
| EP3651771C0 (fr) | Stérilisation par rayonnement de formes posologiques de polymère hypercomprimées | |
| IL269305A (en) | Cannabinoid formulations and dosage | |
| IL285765A (en) | Therapeutic uses of dulaglutide | |
| IL282157A (en) | Compounds and therapeutic uses thereof | |
| EP4034113A4 (fr) | Formulations thérapeutiques et leurs utilisations | |
| MA43114A (fr) | Formulation combinée à dose fixe d'éflornithine et sulindac | |
| IL263976A (en) | Preparations containing memantin and melatonin | |
| PL3843702T4 (pl) | Natychmiastowo uwalniana kombinacja memantyny i donepezilu o ustalonej dawce | |
| HUE066977T2 (hu) | Pán-genotípusos ágensek influenzavírus ellen és azok alkalmazási eljárása |